2024 Annual Meeting | C45 - Core Concepts in Pain Management: Safe and Appropriate Opioid Prescribing in Neurology

Date Sunday 04/14/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | 207

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gil I. Wolfe, MD, FAAN

Topic(s) Pain

Learning Objectives Participants should understand the principles and challenges behind the management of neuropathic pain related to peripheral nervous system disorders; the cascade of neuropathic pain mechanisms, the rationality of combination therapy to address different mechanisms of action, and costs related to opiate use and painful diabetic neuropathy; and pharmacological and alternative approaches in managing these challenging patient issues.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:05 PM - 01:50 PM MDT	Speaker	Core Concepts in Neuropathic Pain Management Gil I. Wolfe, MD, FAAN
01:50 PM - 02:40 PM MDT	Speaker	The Treatment of Neuropathic Pain Nicholas J. Silvestri, MD, FAAN
02:40 PM - 03:00 PM MDT	Q&A	Questions & Answers Gil I. Wolfe, MD, FAAN, Nicholas J. Silvestri, MD, FAAN

Faculty Disclosures
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from ArgenX. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Strongbridge. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Silvestri has received publishing royalties from a publication relating to health care.